NASDAQ:CLYM

Climb Bio Stock Forecast

etoro logo Buy CLYM
*Your capital is at risk
$13.54
-0.460 (-3.29%)
At Close: Aug 10, 2026

Should you buy CLYM stock?

Last updated:

Based on market data through , StockInvest.us rates Climb Bio, Inc. (CLYM) as Hold/Accumulate with a technical score of 0.34 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Down 3.29%
  • 3-month trend forecast Up 24.65%
  • Hold/Accumulate 0.34
AI Analysis AI Analysis of CLYM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CLYM to Watchlist?
Some Reasons Why To Add CLYM:
  • +720.6% price growth over the last year
  • +261.1% YTD performance
  • Lower volatility than the market (beta 0.08)
PDF

Red day on Monday for Climb Bio, Inc.
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Aug 06, 2026 Loss -3.29%

The Climb Bio, Inc. stock price fell by -3.29% on the last day (Monday, 10th Aug 2026) from $14.00 to $13.54. During the last trading day the stock fluctuated 4.66% from a day low at $13.20 to a day high of $13.82. The price has fallen in 7 of the last 10 days but is still up by 5.86% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -134 thousand shares and in total, 777 thousand shares were bought and sold for approximately $10.52 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 24.65% during the next 3 months and, with a 90% probability hold a price between $15.00 and $17.51 at the end of this 3-month period.

CLYM Signals & Forecast

The Climb Bio, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $12.90 and $12.92. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, August 07, 2026, and so far it has fallen -3.29%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Climb Bio, Inc. stock

Climb Bio, Inc. finds support from accumulated volume at $13.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.615 between high and low, or 4.66%. For the last week, the stock has had daily average volatility of 6.94%.

Our recommended stop-loss: $12.84 (-5.15%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CLYM) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Climb Bio, Inc. to open at $13.52, and during the day (based on 14 day Average True Range), to move between $13.06 and $14.02, which gives a possible trading interval of +/-$0.96 (+/-7.34%) up or down from last closing price. If Climb Bio, Inc. takes out the full calculated possible swing range there will be an estimated 7.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.57 (0.22%) than the support at $13.08 (3.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Climb Bio, Inc. stock A Buy?

Climb Bio, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.343 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $13.52 ( 0.160%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CLYM Performance

Trading levels for CLYM

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 14.13 4.38%
R2 13.90 2.65%
R1 13.75 1.58%
Price 13.54
S1 13.28 -1.90%
S2 13.14 -2.97%
S3 12.90 -4.70%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.00 3.40%
R2 13.82 2.07%
R1 13.57 0.222%
Price 13.54
S1 13.08 -3.40%
S2 11.14 -17.76%
S3 10.91 -19.42%

FAQ

What is the symbol for Climb Bio, Inc. Stock and on which exchange is it traded?
The symbol for Climb Bio, Inc. is CLYM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Climb Bio, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Climb Bio, Inc. (CLYM) as Hold/Accumulate with a technical score of 0.34 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 06, 2026, the price has fallen 3.29%. The current 3-month trend forecast projects a rise of 24.65%.

How to buy Climb Bio, Inc. Stock?
Climb Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Climb Bio, Inc. Stock.

What's the current price of Climb Bio, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Climb Bio, Inc. (CLYM) share was $13.54.

What is the 52-week high and low for Climb Bio, Inc. Stock?
The 52-week high for Climb Bio, Inc. Stock is $14.53 and the 52-week low is $1.53.

What is the market capitalization of Climb Bio, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Climb Bio, Inc. is 775.341M.

When is the next earnings date for Climb Bio, Inc.?
The upcoming earnings date for Climb Bio, Inc. is Nov 05, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE